Filter Results
:
(4,316)
Show Results For
-
All HBS Web
(4,316)
- People (14)
- News (1,233)
- Research (2,097)
- Events (8)
- Multimedia (44)
- Faculty Publications (914)
Show Results For
-
All HBS Web
(4,316)
- People (14)
- News (1,233)
- Research (2,097)
- Events (8)
- Multimedia (44)
- Faculty Publications (914)
- June 18, 2021
- Article
Who Do We Invent for? Patents by Women Focus More on Women's Health, but Few Women Get to Invent
By: Rembrand Koning, Sampsa Samila and John-Paul Ferguson
Women engage in less commercial patenting and invention than do men, which may affect what is invented. Using text analysis of all U.S. biomedical patents filed from 1976 through 2010, we found that patents with all-female inventor teams are 35% more likely than...
View Details
Keywords:
Innovation;
Gender Bias;
Health;
Innovation and Invention;
Research;
Patents;
Gender;
Prejudice and Bias
Koning, Rembrand, Sampsa Samila, and John-Paul Ferguson. "Who Do We Invent for? Patents by Women Focus More on Women's Health, but Few Women Get to Invent." Science 372, no. 6548 (June 18, 2021): 1345–1348.
- 05 Sep 2023
- Book
Failing Well: How Your ‘Intelligent Failure’ Unlocks Your Full Potential
recessionary headwinds, the real innovation that can come out of learning from intelligent failures may be what companies most need today. As Edmondson put it, “It’s natural to hunker down and imply that failure is to be avoided in tough...
View Details
Keywords:
by Michael Blanding
- Teaching Interest
Digital Marketing Strategy
By: John A. Deighton
When the tools of marketing change, strategies change too. The focus of this course is on firms trying to navigate the transition from offline to online market-making and strategy development. Our concern is primarily with corporations that have products and... View Details
- November 1992 (Revised June 1993)
- Case
International Paper (A)
Concerns the decision of International Paper, the world's largest pulp and paper corporation, about when to adopt the provisions of Statement of Financial Accounting Standards 106 (SFAS 106), "Employers' Accounting for Postretirement Benefits Other than Pensions." SFAS...
View Details
Barth, Mary E., and Charles A Nichols, III. "International Paper (A)." Harvard Business School Case 193-060, November 1992. (Revised June 1993.)
- January 2023
- Case
Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery
By: Regina Herzlinger and Brian Walker
What should a successful executive (HBS Baker Scholar) assess as her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to successfully commercialize Cleave Therapeutics’ drug for a cancer with no current successful...
View Details
Keywords:
Product Development;
Leadership;
Health Testing and Trials;
Research and Development;
Risk and Uncertainty;
Financial Condition;
Partners and Partnerships;
Pharmaceutical Industry
Herzlinger, Regina, and Brian Walker. "Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery." Harvard Business School Case 323-045, January 2023.
- Web
Managing the Future of Work
collaboration and soft skills through targeted training and mentorship, prioritizing mental health and work-life balance, automating judiciously, and making return-to-office work. Vinson and Elkins' Keith Fullenweider on recruiting team...
View Details
- 04 Jun 2013
- Working Paper Summaries
Prosocial Bonuses Increase Employee Satisfaction and Team Performance
- 02 Sep 2014
- Research & Ideas
Food Stamp Entrepreneurs: How Public Assistance Enables Business Bootstrapping
risks of business ownership and relaxing credit constraints," Olds writes in the 2014 paper "Entrepreneurship and Public Health Insurance." Studying The Social Safety Net Olds grew up on Medicaid, a Federal View Details
- February 2021
- Article
How Transparency into Internal and External Responsibility Initiatives Influences Consumer Choice
By: Ryan W. Buell and Basak Kalkanci
Amid growing calls for transparency and social and environmental responsibility, companies are employing different strategies to improve consumer perceptions of their brands. Some pursue internal initiatives that reduce their negative social or environmental impacts...
View Details
Keywords:
Sustainable Operations;
Corporate Social Responsibility;
Operational Transparency;
Corporate Social Responsibility and Impact;
Operations;
Environmental Sustainability;
Consumer Behavior;
Perception
Buell, Ryan W., and Basak Kalkanci. "How Transparency into Internal and External Responsibility Initiatives Influences Consumer Choice." Management Science 67, no. 2 (February 2021): 932–950.
- Web
CSV Explained - Institute For Strategy And Competitiveness
Explained Creating shared value is a framework for creating economic value while simultaneously addressing societal needs and challenges. When businesses act as businesses —not as charitable donors—they can improve profitability while also improving environmental...
View Details
- June 2021
- Case
Acelero Learning
By: Mario Small, Kathleen L. McGinn, Amy Klopfenstein and Katherine Chen
In November 2020, Henry Wilde, co-founder and CEO of Acelero, Inc., must decide whether to change his company’s program model for delivering early childhood education to low-income children. One of the only for-profit Head Start providers in the United States, Acelero...
View Details
Keywords:
Early Childhood Education;
Organizational Change and Adaptation;
Growth and Development Strategy;
Adoption;
Customer Focus and Relationships;
Operations;
Education Industry;
North and Central America;
United States
Small, Mario, Kathleen L. McGinn, Amy Klopfenstein, and Katherine Chen. "Acelero Learning." Harvard Business School Case 921-029, June 2021.
- Article
Are Buybacks Really Shortchanging Investment?
By: Jesse M. Fried and Charles C.Y. Wang
It’s no secret that the American economy is suffering from the twin ills of slow growth and rising income inequality. Many lay the blame at the doors of America’s largest public corporations. The charge? These firms prefer to distribute cash generated from their...
View Details
Keywords:
Economy;
Investment;
Stocks;
Business and Shareholder Relations;
Equality and Inequality;
United States
Fried, Jesse M., and Charles C.Y. Wang. "Are Buybacks Really Shortchanging Investment?" Harvard Business Review 96, no. 2 (March–April 2018): 88–95.
- 2012
- Other Unpublished Work
Strategic responses to collective activism in the U.S. biomass sector
By: Shon R. Hiatt
Almost all companies face constraints and pressure from collective activists. Using tactics such as protests, boycotts, and lobbying, social movement organizations and collective actors can draw significant media attention to issues facing industries and organizations,...
View Details
- October 2017 (Revised August 2020)
- Case
RB
By: Joshua Margolis, Vincent Dessain and Jerome Lenhardt
As 2016 was approaching its end, Rakesh Kapoor, CEO of RB, one of the world’s major fast moving consumer goods (FMCG) companies, envisioned the prospect of a major acquisition that would add a line of health-related products that promised growth in the developing...
View Details
- September 2017
- Case
Dr. William Carson— Intrapreneurial Innovation in the Pharmaceutical Industry
By: Steven Rogers and Alyssa Haywoode
Dr. William Carson, an African-American alum of Harvard University became the President and CEO of a multi billion dollar division of Otsuka, a Japan based pharmaceutical company. His ascension to this leadership position followed a thriving career in academic medicine...
View Details
Keywords:
Dr. Williams Carson;
Otsuka America Pharmaceutical;
Harvard;
Abilify;
Aripiprazole;
Health Testing and Trials;
Globalized Firms and Management;
Globalized Markets and Industries;
Cross-Cultural and Cross-Border Issues;
Decision Choices and Conditions;
Pharmaceutical Industry;
Japan
Rogers, Steven, and Alyssa Haywoode. "Dr. William Carson— Intrapreneurial Innovation in the Pharmaceutical Industry." Harvard Business School Case 318-005, September 2017.
- March 2008
- Case
Novartis AG: Science-Based Business
By: H. Kent Bowen and Courtney Purrington
Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in 2007. Pharmaceuticals account for slightly over $24B of that total. In 2007,...
View Details
Keywords:
Innovation and Invention;
Resource Allocation;
Product Development;
Partners and Partnerships;
Research and Development;
Science-Based Business;
Pharmaceutical Industry
Bowen, H. Kent, and Courtney Purrington. "Novartis AG: Science-Based Business." Harvard Business School Case 608-136, March 2008.
- Program
Leading and Building a Culture of Innovation
chief technology officers, chief information officers, and chief HR executives Leaders from corporate strategy, finance, legal, human resources, marketing, manufacturing, customer service, and sales Individuals and teams are welcome to attend. Participation by multiple...
View Details
James I. Cash
Professor Cash received a Bachelor of Science degree in Mathematics from Texas Christian University; a Master of Science in Computer Science from Purdue University's Graduate School of Mathematical Sciences; and a Doctor of Philosophy in Management Information... View Details
- Web
Initiatives | About
Initiatives Critical mass and critical thinking around critically important topics. Business & Environment Business History Entrepreneurship (Rock Center) Health Care Leadership Race, Gender & Equity Social Enterprise Initiatives are...
View Details
- October 2012 (Revised October 2016)
- Case
Predilytics
By: Robert F. Higgins and Annelena Lobb
The management team at Predilytics, a healthcare analytics firm, must decide whether to accept a Series A venture capital financing deal. The company provided analytic services to healthcare plans, typically Medicare Advantage plans, in efforts to draw conclusions from...
View Details
Keywords:
Analytics;
Healthcare;
Medicare;
Health Care and Treatment;
Mathematical Methods;
Health Industry;
New England;
United States
Higgins, Robert F., and Annelena Lobb. "Predilytics." Harvard Business School Case 813-023, October 2012. (Revised October 2016.)